Search - tctmd.com

Displaying 221 - 240 of 364

Sort: Relevancy | Date

News Industry News

CeloNova Announces FDA Approval to Start a Randomized Trial for the COBRA PzF™ Coronary Stent System

September 21, 2015

News Conference News ESC 2015

EXAMINATION: STEMI Patients Fare Better at 5 Years With EES vs BMS

Caitlin E. Cox

September 02, 2015

Presentation ESC 2015

12 vs 48 months of dual antiplatelet therapy after drug-eluting stent placement: The OPTIDUAL Randomized Trial

Presenter: G?rard Helft

August 31, 2015

News Daily News

SES Fracture Linked to Worse Long-term Outcomes

August 31, 2015

News Conference News ESC 2015

OPTIDUAL: No Clear Need to Lengthen DAPT to 4 Years After DES

Caitlin E. Cox

August 31, 2015

News Daily News

DES Patients Who Bleed After Hospital Discharge Face Higher Mortality Risk

Todd Neale

August 31, 2015

News Industry News

First U.S. Patients Enroll in Boehringer Ingelheim's Global RE-DUAL PCI™ and RE-CIRCUIT™ Trials Evaluating Pradaxa® (dabigatran etexilate mesylate)

July 29, 2015

News Daily News

BASKET-PROVE Substudy: DES Better Than BMS in Elderly Patients With Large Arteries

Yael L. Maxwell

July 29, 2015

News Industry News

OrbusNeich Announces Enrollment of First Patient in China Recovery Study

July 20, 2015

News Daily News

DES, BMS Both Suitable for Treating Patients With SVG Lesions

July 20, 2015

News Daily News

RIBS IV: EES Surpass DCB for Treatment of In-Stent Restenosis

L.A. McKeown

July 01, 2015

News Daily News

With Newer-Generation DES, Ultralong Stenting Tied to Adverse Events

Nicole Lou

June 16, 2015

News Industry News

QT Vascular Announces First Patients Enrolled In Clinical Study Of Chocolate Touch™ PTCA Coronary Drug-Coated Balloon

May 20, 2015

News Industry News

Early Healing Profile Established for BioFreedom

May 20, 2015

News Industry News

OrbusNeich Announces Initiation of HARMONEE Stent Study in US

May 18, 2015

News Daily News

DAPT Substudy: No Apparent Benefit of Long-term DAPT in BMS Patients

Yael L. Maxwell

March 24, 2015

Presentation

Short- vs Long-term Dual Antiplatelet Therapy After DES Implantation

Presenter: T. Palmerini

March 18, 2015

News Daily News

ZEUS发布：在“不确定”DES候选者中，带个性化DAPT的ZES胜过裸金属支架

L.A. McKeown

February 25, 2015

News Daily News

ZEUS Published: ZES With Personalized DAPT Bests Bare-Metal Stent in ‘Uncertain’ DES Candidates

L.A. McKeown

February 25, 2015

News Daily News

ZEUS Publicado: Los SLZ + Tratamiento Antiplaquetario Doble Personalizado Superan a los SMD en Candidatos SLF ‘Inciertos’

L.A. McKeown

February 25, 2015

Advertisement

CeloNova Announces FDA Approval to Start a Randomized Trial for the COBRA PzF™ Coronary Stent System

EXAMINATION: STEMI Patients Fare Better at 5 Years With EES vs BMS

12 vs 48 months of dual antiplatelet therapy after drug-eluting stent placement: The OPTIDUAL Randomized Trial

SES Fracture Linked to Worse Long-term Outcomes

OPTIDUAL: No Clear Need to Lengthen DAPT to 4 Years After DES

DES Patients Who Bleed After Hospital Discharge Face Higher Mortality Risk

First U.S. Patients Enroll in Boehringer Ingelheim's Global RE-DUAL PCI™ and RE-CIRCUIT™ Trials Evaluating Pradaxa® (dabigatran etexilate mesylate)

BASKET-PROVE Substudy: DES Better Than BMS in Elderly Patients With Large Arteries

OrbusNeich Announces Enrollment of First Patient in China Recovery Study

DES, BMS Both Suitable for Treating Patients With SVG Lesions

RIBS IV: EES Surpass DCB for Treatment of In-Stent Restenosis

With Newer-Generation DES, Ultralong Stenting Tied to Adverse Events

QT Vascular Announces First Patients Enrolled In Clinical Study Of Chocolate Touch™ PTCA Coronary Drug-Coated Balloon

Early Healing Profile Established for BioFreedom

OrbusNeich Announces Initiation of HARMONEE Stent Study in US

DAPT Substudy: No Apparent Benefit of Long-term DAPT in BMS Patients

Short- vs Long-term Dual Antiplatelet Therapy After DES Implantation

ZEUS发布：在“不确定”DES候选者中，带个性化DAPT的ZES胜过裸金属支架

ZEUS Published: ZES With Personalized DAPT Bests Bare-Metal Stent in ‘Uncertain’ DES Candidates

ZEUS Publicado: Los SLZ + Tratamiento Antiplaquetario Doble Personalizado Superan a los SMD en Candidatos SLF ‘Inciertos’

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content